Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2023, 5(5); doi: 10.25236/FMSR.2023.050508.

Research progress of cyclosporine A in treatment of recurrent abortion

Author(s)

Junlei Zhang1, Nan Li2, Wenjun Liu1, Xiaoyuan Xing1

Corresponding Author:
Nan Li
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China

Abstract

Recurrent spontaneous abortion (RSA) is one of the common complications of pregnancy in obstetrics and gynecology, and it seriously threatens the physical and mental health of women in the reproductive period. The etiology of RSA is complex, and based on the basic national conditions and clinical practice in China, it is found that the incidence rate of RSA among women of childbearing age increases year by year. At present, the etiology of some patients with RSA is unknown, and some studies have reported that its pathogenic factors are closely related to immune abnormalities. At present, immunization-related therapeutic scheme of RSA has attracted more and more attention from scholars. Many studies have found that the immunosuppressive agent A (cyclosporine A, CsA) has an affirmative effect on the prevention and treatment of RSA by benign regulation of maternal-fetal immune tolerance and positive regulation of trophoblast biological function. However, the application of CsA in the reproduction field is still in the exploratory stage, and there are no standardized treatment standards, large samples and high quality clinical trials. In view of this, we reviewed the mechanism of action of CsA in the treatment of RSA and the research progress of combination therapy in recent years, in order to provide new theoretical support for the subsequent clinical treatment of RSA.

Keywords

cyclosporine A; recurrent abortions; Maternal and fetal immune tolerance; nurse cell

Cite This Paper

Junlei Zhang, Nan Li, Wenjun Liu, Xiaoyuan Xing. Research progress of cyclosporine A in treatment of recurrent abortion. Frontiers in Medical Science Research (2023) Vol. 5, Issue 5: 49-56. https://doi.org/10.25236/FMSR.2023.050508.

References

[1] Fu J H. Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion [J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 739-742.

[2] Gaizhen R U, Yuanhua H, Ying-pu S U N. Researches in CsA and It’s Application in Obstetrics and Reproduction [J]. Journal of International Reproductive Health/Family Planning, 2011, 30(3): 230-233.   

[3] Writing Group of Chinese Expert Consensus on Diagnosis and Treatment of Spontaneous Abortion. Chinese expert consensus on diagnosis and treatment of spontaneous abortion (2020 edition)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2020, 36 (11): 1082-1090.

[4] Shi Qingyang, Li Chunhong, Feng LiHua. Progress in study on immunopathology of unexplained recurrent spontaneous abortion[J]. Chinese Journal of Laboratory Diagnosis,2010,014(001):153-155.

[5] Yan Shu, Wang Kehua. Advance in the diagnosis and treatment of recurrent miscarriage in traditional Chinese and western medicine[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2021,30(11):1249-1254.

[6] Wang Jing, Cao Wenli, Zhu Jun, et al. Research progress of maternal  fetal immune tolerance and the etiology of unexplained recurrent spontaneous abortion[J]. Chinese Journal of Obstetrics and Gynecology, 2021, 56(9) : 652-655.

[7] Dai Ying, Zhang Jing, Lin Meiqing, Song Hongtao. Research current situation and progress on pharmacogenomics and personalized medicine of cyclosporine A [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 931-936.

[8] Zheng Jing. Role of Calcineurin/Nuclear factor of activated T cells pathway in Rat Aorta Calcification [D]. Hebei Medical University, 2009. 

[9] Zhong M, Cheng G F, Wang W J, et al. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice [J]. Phytomedicine, 1999, 6(2): 79-84.

[10] Zhang M, Yao Q, Sun B H, et al. Inducement and production of tumor necrosis factor by murine peritoneal macrophage [J]. J Immunol (Chinese), 1991, 7: 254-7.

[11] Expert Coordination Group in Application of Cyclosporine A in Nephrology. Consensus on the Application of Cyclosporine A in the Treatment of Glomerular Diseases[J].Chinese Journal of Nephrology, 2005,21,(09):556-557.

[12] Wu R., Luo S.J., Li Z.D., Qin W.J., Liu Y.N., Pei Z. and Huang R.X. Cyclosporine A inhibits inflammation and improves the neurological function in a rat model of cerebral ischemia reperfusion [J]. Chinese journal of nervous and mental diseases, 2015,41(05):299-303.

[13] Yang Yanning, Zhu Jiayue, Song Xiusheng, Li Xia, Li Tuo, Li Jiazhang. Current progress on clinical application of cyclosporine A [J]. International Eye Science, 2017(03):463-466.

[14] Gui Q, Jiang Z, Zhang L. Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation [J]. International Immunopharmacology, 2021, 93(4):107420.

[15] Matsuda S, Koyasu S. Mechanisms of action of cyclosporine[J]. Immunopharmacology, 2000, 47(2-3): 119-125.

[16] Huang Yuanhua. Molecular mechanisms by which cyclosporine A improves mouse embryo implantation [D]. Fudan University. 2014.

[17] Wang Xianli, Zeng Tao, Yang Zhenyu. Modulation of Cyclosporin A on Pregnancy[J]. Chinese Journal of Modern Applied Pharmacy, 2015, 32 (05): 629-634.   

[18] Zhang Tao, Lian Ruochun, Lin jiayin, Zhang Xu, Zeng Yong, Huang Chunyu. Effect of cyclosporin A on IFN-γ and TNF-α in peripheral blood of patients with unexplained recurrent miscarriage [J].Journal of Reproductive Medicine .2017, 26(3):244-248.

[19] Bansal AS. Joining the immunological dots in recurrent miscar-riage[J]. Am J Reprod Immunol, 2010, 64(5): 307-315.

[20] Sasaki A, Kuroda K, Hisano M, Ozawa N, Sago H, Yamaguchi K. Successful treatment for a recurrent pregnancy loss woman with high Th1/Th2 ratio using medium-dose corticosteroids[J]. J Obstet Gynaecol. 2017 Jul; 37(5):685-687.

[21] Dong Lin, Du Meirong, Zhu Xiaoyong, et al. Effect of cyclosporine A on pregnancy outcome and its molecular mechanism in a mouse model of spontaneous abortion [C]. 5th National Congress and Academic Conference of China Association of Immunology.

[22] Li Mingqing, Du Meirong, Zhou Wenhui, Li Dajin. The regulation of cyclosporin A on the ratio of IL-10 to IFN-γ at human maternal-fetal interface[J]. Current Immunology,2011,31(2):121-125.

[23] Chen Yong, Yu Yuexin. Effect of combined cyclosporine A in treatment of refractory unexplained recurrent spontaneous abortion[J]. Clinical Journal of Medical Officers, 2017,45(10):1039-10411045.

[24] Wu Weihua, Pu Yujiang, Zhang Lin, et al. The relationship between HMGB1 level in peripheral blood and Th17 /Treg cells in patients with unexplained recurrent spontaneous abortion [J]. Maternal and Child Health Care of China, 2018, 33(11):2541-2543.

[25] Guan Guixue, Yan Lei. Treatment of the Recurrent Spontaneous Abortion Caused by Dysimmunity and Prethrombotic State [J]. Journal of International Reproductive Health/Family Planning, 2018, 37(2): 145-149.

[26] Wang S, Li M, Sun F, Chen C, Ye J, Li D, Qian J, Du M. Th17/Treg-cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A [J]. Exp Ther Med.2021 Jan;21(1):37.

[27] Yang H, Qiu LH, Chen GJ. Proportional change of CD4 CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients [J]. Fertil Steril, 2008, 89(3):656-661.

[28] Li Dajin, Tang Chuanling, Du Meirong. The Favorable Modulation of Cyclosporin A on the Biological Behaviors of Trophoblast Cells [J]. International Journal of Reproductive Health and Family Planning, 2013, 32(06): 438-441.

[29] Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism[J]. Nature.1999 Feb 11; 397(6719):530-534.

[30] Yan Fengting, Li Dajin, Sun Xiaoxi, et al. Effect of cyclosporin A on the growth of human first trimester cytotrophoblasts in vitro [J]. Chinese Journal of Obstetrics and Gynaecology, 2002, 37 (2):74-76.

[31] Tang Chuanling. Cyclosporin A Attenuates the oxidative Injury of Human Trophoblast Cells[D]. Fudan University.2012.

[32] Zhao HB, Wang C, Li RX, et al. E -Cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down- regulated by cyclosporin A via epidermal growth factor/ extracelluatr signal -Regulated protein kinase signaling pathway [J]. Biol Reprod, 2010, 83(3): 370- 376.

[33] Tong Xinxin, Jin Hongyan, Yang Huixia. Research progress of molecular mechanism of cyclosporine A regulating pregnancy [J]. Chinese Journal of Obstetrics and Gynecology, 2016, 51(12): 946-949.

[34] Tang CL, Zhao HB, Li MQ, et al. Focal adhesion kinase signaling is necessary for the Cyclosporin A - enhanced migration and invasion of human trophoblast cells[J]. Placenta, 2012, 33(9): 704- 711.

[35] Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype [J]. Annu Rev Cell Dev Biol, 2003, 19:207-235.

[36] Hung TH, Chen SF, Liou JD, et al. Bax, Bak and mitochon-drial oxidants are involved in hypoxia-reoxygenation-induced apoptosis in human placenta [J]. Placenta, 2008, 29(7):565-583.

[37] Xiong Yanhong. Clinical observation of Cyclosporine A combined with Low Molecular Weight Heparin in unexplained recurrent abortion [D]. Youjiang Medical University for Nationalities.2021.

[38] Yang Chunyan. Clinical study of Bushen Antai Prescription combined with Cyclosporin A in the treatment of unexplained recurrent spontaneous abortion of kidney deficiency type [D]. Jiangxi University of Traditional Chinese Medicine.2019.